home / stock / inzy / inzy news

INZY News and Press, Inozyme Pharma Inc.

Stock Information
Company Name: Inozyme Pharma Inc.
Stock Symbol: INZY
Market: NASDAQ
Website: inozyme.com
Menu
INZY INZY Quote INZY Short INZY News INZY Articles INZY Message Board
Get INZY Alerts

News, Short Squeeze, Breakout and More Instantly...
INZY - Inozyme gets Fast Track status for candidate for rare calcification condition

2024-07-02 13:43:54 ET More on Inozyme Pharma Seeking Alpha’s Quant Rating on Inozyme Pharma Historical earnings data for Inozyme Pharma Financial information for Inozyme Pharma Read the full article on Seeking Alpha For further details see: ...
INZY - Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency

BOSTON, July 02, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal prolifer...

INZY - Inozyme Pharma Announces Presentation and Sponsored Symposium at the 11th International Conference on Children's Bone Health (ICCBH)

BOSTON, June 21, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferatio...

INZY - Inozyme Pharma to Present at the Jefferies Global Healthcare Conference

BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation...
INZY - INZY Price Target Alert: $14.00. Issued by Wells Fargo

2024-05-30 07:00:07 ET Tiago Fauth from Wells Fargo issued a price target of $14.00 for INZY on 2024-05-30 05:39:00. The adjusted price target was set to $14.00. At the time of the announcement, INZY was trading at $4.51. The overall price target consensus is at $14.00 w...

INZY - Inozyme Pharma to Present Recently Announced Data from Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) at Upcoming Medical Conferences

BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal prolifera...

INZY - Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference

BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation...
INZY - Inozyme Pharma GAAP EPS of -$0.38 beats by $0.02

2024-05-08 03:54:18 ET More on Inozyme Pharma Inozyme: Several Catalysts To Move Rare Disease Pipeline Programs Forward Seeking Alpha’s Quant Rating on Inozyme Pharma Historical earnings data for Inozyme Pharma Financial information for Inozyme Pharma ...

INZY - Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights

- Interim data from SEAPORT-1, a Phase 1 trial of INZ-701 in patients with end-stage kidney disease receiving hemodialysis, on track for fourth quarter of 2024 - - Interim data from ENERGY-1, a Phase 1b trial of INZ-701 in infants with ENPP1 Deficiency, on track for second half of 2024 ...

INZY - RMBS, SANM and WGS are among after hour movers

2024-04-29 17:00:21 ET Gainers: GeneDx Holdings  ( WGS ) +22% . Zapp Electric Vehicles Group  ( ZAPP ) +8% . Amkor Technology ( AMKR ) +7% . Woodward ( WWD ) +6% . NXP Semiconductors ( NXPI ) +5% . Losers: F5 ( ...
Next 10